©2019 by Jon Holden DeHaan Foundation.



Posted June 6, 2019 – In May, the Jon DeHaan Foundation, together with PCR, was proud to present Filterlex with the Award for Innovation in Cardiology at PCR Innovators Day in Paris, France.

Filterlex was one of six candidates to present for the $200 000 award at a dedicated session at PCR. The judging panel was made up of medical professionals and investors from the Interventional Cardiology community.

Filterlex has developed Captis, a next-generation full-body embolic protection device for use during TAVI procedures. It has been designed with the goal of reducing the risk of stroke and other complications during catheter-based structural heart procedures.

Giora Weisz says, “With the generous Jon DeHaan Foundation grant, we will be able to further develop and soon to bring to patients a mature and improved device to protect them.”

The Jon DeHaan Foundation is excited to support companies like Filterlex in their groundbreaking research towards commercialization. Our partnership with PCR strengthens both organizations’ missions of presenting and encouraging innovative technologies in the cardiovascular field, both at an early stage and up to the level of first-in-man evaluation.

Related Content

Filterlex Medical Raised $3M in Series A Financing

The European Commission Horizon 2020 Program Backs Filterlex's Embolic Protection Device - CAPTIS